CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The CHARME project aims to commercialize EpitaxOs, a novel bone regeneration material that promotes natural bone growth without the drawbacks of traditional grafts. Targeting the spinal and dental markets, EpitaxOs is designed to enhance patient outcomes by providing a safer and more effective alternative for bone repa…
XPAND Biotechnology BV has developed a new generation of orthopaedic materials: the EpitaxOs bone regeneration material.
EpitaxOs (TRL 6) is unique:a) it seduces the body to form boneb) is as effective as the golden standard autograft without its disadvantages (extra operative procedure, pain, limited quantity available)c) it is superior to other synthetic bone graft materials, allograft, growth factors and cell-based technologiesd) it is available in abundant quantities e) it increases the qual…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
